Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo.

Yuan Y, Orlow SJ, Curtin J, Downey A, Muggia F

DOI: 10.3332/ecancer.2008.111
Published: 2008
Container: Ecancermedicalscience
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3332/ecancer.2008.111,
  title = {Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo.},
  author = {Yuan Y and Orlow SJ and Curtin J and Downey A and Muggia F},
  year = {2008},
  journal = {Ecancermedicalscience},
  doi = {10.3332/ecancer.2008.111},
  url = {https://doi.org/10.3332/ecancer.2008.111}
}

RIS

TY  - JOUR
TI  - Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo.
AU  - Yuan Y
AU  - Orlow SJ
AU  - Curtin J
AU  - Downey A
AU  - Muggia F
PY  - 2008
JO  - Ecancermedicalscience
DO  - 10.3332/ecancer.2008.111
UR  - https://doi.org/10.3332/ecancer.2008.111
ER  -

APA

Y, Y., SJ, O., J, C., A, D., & F, M. (2008). Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo.. Ecancermedicalscience. https://doi.org/10.3332/ecancer.2008.111

Source records

pubmed · retrieved 2026-09-26T18:15:47.740Z